The EFF is a growing multiple stakeholder platform for the exchange and sharing of insights and innovations to drive the future of clinical development in inherited retinal diseases. Organized by ProQR
ProQR will host a virtual Analyst and Investor Event on Wednesday, December 11, 2024 from 10:00 am until approximately 12:30 pm EST, including an Analyst Q&A session with members of the ProQR Management Team.
… an office in Cambridge, Massachusetts, USA, developing innovative RNA-editing medicines through its proprietary … Our Clinical Development team translates scientific innovation into rigorous clinical studies and development … closely with colleagues across the organization to advance innovative RNA-editing therapeutics in liver and central …